home.social

#gsk — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #gsk, aggregated by home.social.

  1. GSK to Advance mRNA Influenza Vaccine Into Phase III Development

    GSK plc GSK announced that it plans to advance the mRNA-based seasonal influenza (flu) vaccine candidate into late-stage development.…
    #EuropeSays #Britain #Europe #EU #GSK #AnikaTherapeutics #AnikaTherapeuticsANIK #GSKPLCSponsoredADR #PLC) #Repligen #RepligenRGEN #Zacks #ZacksInvestmentResearch
    europesays.com/britain/118817/

  2. GSK (LSE:GSK), What Is Behind The Latest Attention?

    GSK (LSE:GSK) is back in focus after presenting positive phase II data for its mRNA seasonal flu vaccine…
    #EuropeSays #Britain #Europe #EU #GSK
    europesays.com/britain/118415/

  3. GSK advances mRNA flu vaccine to phase 3 after positive results

    (Alliance News) – GSK PLC on Tuesday said a phase 2 probe of its mRNA flu vaccine candidate…
    #EuropeSays #Britain #Europe #EU #GSK
    europesays.com/britain/117985/

  4. europesays.com/britain/117985/ GSK advances mRNA flu vaccine to phase 3 after positive results #GSK

  5. Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830

    (Alliance News) – Hutchmed China PLC on Thursday announced that its subsidiary, Hutchmed Ltd, has entered into an…
    #EuropeSays #Britain #Europe #EU #GSK
    europesays.com/britain/117974/

  6. europesays.com/britain/117974/ Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830 #GSK

  7. Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity?

    GSK plc (NYSE:GSK) has reached two important regulatory milestones involving treatments for chronic hepatitis B and rectal cancer.…
    #EuropeSays #Britain #Europe #EU #GSK #GSKplc #Jemperli #NYSE
    europesays.com/britain/117964/

  8. Hesham A. Abdullah Announces a New Oncology Partnership Between GSK and HUTCHMED

    Hesham A. Abdullah/LinkedIn Hesham A. Abdullah, Senior Vice President of Global Head Oncology, Research and Development at GSK…
    #EuropeSays #Britain #Europe #EU #GSK
    europesays.com/britain/117866/

  9. europesays.com/britain/117866/ Hesham A. Abdullah Announces a New Oncology Partnership Between GSK and HUTCHMED #GSK

  10. HUTCHMED Secures $110 Million Licensing Deal with GSK for Promising Solid Tumour Drug, ETPharma

    Shanghai: GSK subsidiary GlaxoSmithKline Intellectual Property (No. 4) Ltd will pay a unit of HUTCHMED (China) $110 million…
    #EuropeSays #Britain #Europe #EU #GSK #experimentalsolidtumourdrug #GlaxoSmithKline #HMPL-A830 #HUTCHMEDlicensingdeal #solidtumours
    europesays.com/britain/117654/

  11. GSK advances mRNA flu shot after Phase II success

    Drugmaker GSK said on Tuesday that it will move its mRNA seasonal flu vaccine candidate into Phase III…
    #EuropeSays #Britain #Europe #EU #GSK #advances #after #Category:All #Category:CompanyNews #Category:MarketPulse #Category:MarketReport #Category:NewsandAnnouncements #Category:Sectorial:HealthTechnology #mRNA #Phase #shot #success
    europesays.com/britain/117636/

  12. europesays.com/britain/117636/ GSK advances mRNA flu shot after Phase II success #advances #after #Category:All #Category:CompanyNews #Category:MarketPulse #Category:MarketReport #Category:NewsAndAnnouncements #Category:Sectorial:HealthTechnology #GSK #mRNA #Phase #shot #success

  13. Hutchmed, GSK Ink $1.3B Cancer Drug Deal

    Hutchmed Limited has entered into an exclusive development and license agreement with a subsidiary of GSK plc, giving…
    #EuropeSays #Britain #Europe #EU #GSK
    europesays.com/britain/117616/

  14. Is GSK (LSE:GSK) Still Reasonable, Or Is The Value Already Priced In?

    GSK stock has delivered a strong 54.4% gain over the past 5 years, yet the current checks still…
    #EuropeSays #Britain #Europe #EU #GSK
    europesays.com/britain/117597/

  15. europesays.com/britain/117597/ Is GSK (LSE:GSK) Still Reasonable, Or Is The Value Already Priced In? #GSK

  16. GSK (LSE:GSK) Wins First Global Approval For Chronic Hepatitis B Functional Cure

    GSK (LSE:GSK) has received the world’s first regulatory approval for Hibsago (bepirovirsen) as a functional cure for chronic…
    #EuropeSays #Britain #Europe #EU #GSK
    europesays.com/britain/117584/

  17. europesays.com/britain/117584/ GSK (LSE:GSK) Wins First Global Approval For Chronic Hepatitis B Functional Cure #GSK

  18. China’s Hutchmed inks $1.3 B deal with GSK for KRAS-EGFR-antibody conjugate cancer therapy

    China’s Hutchmed inks $1.3 B deal with GSK for KRAS-EGFR-antibody conjugate cancer therapy September 4, 2026 | Friday…
    #EuropeSays #Britain #Europe #EU #GSK #Cancer #China #EGFR #Hutchmed #KRAS
    europesays.com/britain/117573/

  19. HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug

    Sept 3 (Reuters) – GSK subsidiary GlaxoSmithKline Intellectual Property (No. 4) Ltd will pay a unit of HUTCHMED…
    #EuropeSays #Britain #Europe #EU #GSK #Markets
    europesays.com/britain/117557/

  20. europesays.com/britain/117557/ HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug #GSK #Markets

  21. GSK to Advance mRNA Influenza Vaccine Into Phase III Development

    GSK plc GSK announced that it plans to advance the mRNA-based seasonal influenza (flu) vaccine candidate into late-stage development.…
    #EuropeSays #Britain #Europe #EU #GSK #AnikaTherapeutics #AnikaTherapeuticsANIK #GSKPLCSponsoredADR #PLC) #Repligen #RepligenRGEN #Zacks #ZacksInvestmentResearch
    europesays.com/britain/117543/

  22. GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank says

    GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank says Proactive uses images sourced from Shutterstock GSK…
    #EuropeSays #Britain #Europe #EU #GSK #deutschebank #Moderna
    europesays.com/britain/117528/

  23. Is GSK (LSE:GSK) Losing The Room As Vaccine Demand Questions Resurface?

    Highlights GSK featured among the sharpest decliners on London’s leading benchmark Vaccine demand patterns remain the most closely…
    #EuropeSays #Britain #Europe #EU #GSK #IsGSK(LSE:GSK)LosingTheRoomAsVaccineDemandQuestionsResurface?
    europesays.com/britain/117512/

  24. GSK hopes to take on Moderna as it moves mRNA flu vaccine to Phase III trial

    GSK’s seasonal, mRNA-based influenza vaccine is progressing to a Phase III study after securing a safety and efficacy…
    #EuropeSays #Britain #Europe #EU #GSK #August2025 #august2026 #british #ClinicalTrialsArena #GlobalData #mFlusvia #Moderna #PhaseIII #RFKJr
    europesays.com/britain/115793/

  25. Padilha anuncia compra do cabotegravir, PrEP de longa duração

    No AIDS 2026, ministro da Saúde tornou pública a aquisição do medicamento de HIV. Também informou sobre o impasse do lenacapavir e um acordo para acompanhar o desenvolvimento do alimatravir

    outraspalavras.net/outrasaude/

  26. GSK купує американську біотех-компанію Nuvalent за $10,6 млрд — це найбільша угода виробника за останні вісім років. Премумія в 40% свідчить про стратегічний розворот назад до онкології після років скорочення цього напряму.

    Злиття та поглинання у фармацевтиці — один із ключових індикаторів настроїв у секторі охорони здоров'я. Коли великі гравці платять значну премію за доступ до нових технологій, це часто дає імпульс суміжним компаніям і підвищує увагу до біотех-стартапів на ранніх стадіях.

    Для українського інвестора це нагадування: стежте за M&A активністю у фармі та біотеху — вона часто випереджає загальне зростання сектора.

    #GSK #MergersAndAcquisitions #Biotech #Онкологія #Інвестиції #Фармацевтика

    #virgroup

    vir.group/post/116719449498412